Illuminating the Frontier of Drug Discovery: Unleashing the Power of Bioinformatics for Unprecedented Breakthroughs

Year : 2023 | Volume : 01 | Issue : 02 | Page : 1-10
    By

    S. Luqman Ali,

  • Awais Ali,

  • Waseef Ullah,

  • Kashif Adil,

  • M. Usman,

  1. M.phill Scholars, , Department of Biochemistry, Abdul Wali khan university, Mardan, Pakistan
  2. M.phill Scholars, Department of ichemistry, Abdul Wali khan university, Mardan, Pakistan
  3. Students, Department of Biochemistry, Abdul Wali khan university, Mardan, Pakistan
  4. Students, Department of Biochemistry, Abdul Wali khan university, Mardan, Pakistan
  5. Students, Students, Department of Biochemistry, Abdul Wali khan university, Mardan, Pakistan

Abstract

It takes a long time and a lot of effort to discover and develop new drugs, which necessitates extensive study and testing. With the help of computational techniques and data analysis, bioinformatics has grown to be a potent tool for drug discovery in recent years, allowing researchers to find new drugs faster. In this review, we examine the role of bioinformatics in drug discovery, including the use of ligand- and structure-based drug design, virtual screening based on pharmacophore models, de novo design based on pharmacophore models, and quantitative structure-activity relationship (QSAR) models and machine learning techniques. We also talk about how important data collection from different sources, like natural and synthetic databases, is for supporting drug discovery efforts. We highlight the potential of bioinformatics to revolutionise the field of drug discovery and to hasten the creation of new medications for the treatment of a variety of diseases through an analysis of recent researc

Keywords: Bioinformatics, Drug discovery, Ligand-based drug design, Structure-based drug design, Virtual screening, QSAR, Machine learning, Data assortment

[This article belongs to International Journal of Molecular Biotechnological Research ]

How to cite this article:
S. Luqman Ali, Awais Ali, Waseef Ullah, Kashif Adil, M. Usman. Illuminating the Frontier of Drug Discovery: Unleashing the Power of Bioinformatics for Unprecedented Breakthroughs. International Journal of Molecular Biotechnological Research. 2023; 01(02):1-10.
How to cite this URL:
S. Luqman Ali, Awais Ali, Waseef Ullah, Kashif Adil, M. Usman. Illuminating the Frontier of Drug Discovery: Unleashing the Power of Bioinformatics for Unprecedented Breakthroughs. International Journal of Molecular Biotechnological Research. 2023; 01(02):1-10. Available from: https://journals.stmjournals.com/ijmbr/article=2023/view=123733



Browse Figures

References

1. Parikh, P. K., Savjani, J. K., Gajjar, A. K., & Chhabria, M. T. (2023). Bioinformatics and Cheminformatics Tools in Early Drug Discovery. Bioinformatics Tools for Pharmaceutical Drug Product Development, 147–181.
2. Ajjarapu, S. M., Tiwari, A., Ramteke, P. W., Singh, D. B., & Kumar, S. (2022). Ligand-based drug designing. In Bioinformatics (pp. 233–252). Elsevier.
3. Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014). Computational methods in drug discovery. Pharmacological Reviews, 66(1), 334–395.
4. Rastogi, S. C., Rastogi, P., & Mendiratta, N. (2022). Bioinformatics: Methods and Applications-Genomics, Proteomics and Drug Discovery. PHI Learning Pvt. Ltd.
5. Hemmerling, F., & Piel, J. (2022). Strategies to access biosynthetic novelty in bacterial genomes for drug discovery. Nature Reviews Drug Discovery, 21(5), 359–378.
6. Deng, J., Yang, Z., Ojima, I., Samaras, D., & Wang, F. (2022). Artificial intelligence in drug discovery: applications and techniques. Briefings in Bioinformatics, 23(1).
7. Irham, L. M., Adikusuma, W., & Perwitasari, D. A. (2022). Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach. Biochemistry and Biophysics Reports, 32, 101334.
8. Labjar, H., Labjar, N., & Kissi, M. (2022). QSAR Anti-HIV Feature Selection and Prediction for Drug Discovery Using Genetic Algorithm and Machine Learning Algorithms. In Computational Intelligence in Recent Communication Networks (pp. 191–204). Springer.
9. Winkler, D. A. (2022). The impact of machine learning on future tuberculosis drug discovery. Expert Opinion on Drug Discovery, 17(9), 925–927.
10. Gertrudes, J. C., Maltarollo, V. G., Silva, R. A., Oliveira, P. R., Honorio, K. M., & Da Silva, A. B. F. (2012). Machine learning techniques and drug design. Current Medicinal Chemistry, 19(25), 4289–4297.
11. Neves, B. J., Braga, R. C., Melo-Filho, C. C., Moreira-Filho, J. T., Muratov, E. N., & Andrade, C. H. (2018). QSAR-based virtual screening: advances and applications in drug discovery. Frontiers in Pharmacology, 9, 1275.
12. Crampon, K., Giorkallos, A., Deldossi, M., Baud, S., & Steffenel, L. A. (2022). Machine-learning methods for ligand–protein molecular docking. Drug Discovery Today, 27(1), 151–164.
13. Ugbaja, S. C., Mtambo, S. E., Mushebenge, A. G., Appiah-Kubi, P., Abubakar, B. H., Ntuli, M. L., & Kumalo, H. M. (2022). Structural Investigations and Binding Mechanisms of Oseltamivir Drug Resistance Conferred by the E119V Mutation in Influenza H7N9 Virus. Molecules, 27(14). https://doi.org/10.3390/molecules27144376
14. Yao, H., Liu, J., Xu, M., Ji, J., Dai, Q., & You, Z. (2022). Discussion on molecular dynamics (MD) simulations of the asphalt materials. Advances in Colloid and Interface Science, 299, 102565.

Regular Issue Subscription Review Article
Volume 01
Issue 02
Received 14/06/2023
Accepted 23/06/2023
Published 15/07/2023
Publication Time 31 Days
Total Visits: 357


My IP

PlumX Metrics